 Heres a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks Biotech stocks hitting 52-week highs on Jan. 23 Baudax Bio Inc NASDAQ: BXRX Mesoblast limited NASDAQ: MESO Nevro Corp NYSE: NVRO Oyster Point Pharma Inc NASDAQ: OYST Soligenix, Inc. NASDAQ: SNGX Syneos Health Inc NASDAQ: SYNH TELA Bio Inc NASDAQ: TELA Trillium Therapeutics Inc NASDAQ: TRIL Y-mAbs Therapeutics, Inc NASDAQ: YMAB Zai Lab Ltd NASDAQ: ZLAB Down In The Dumps Biotech stocks hitting 52-week lows on Jan. 23 Avanos Medical Inc NYSE: AVNS Blueprint Medicines Corp NASDAQ: BPMC Enanta Pharmaceuticals Inc NASDAQ: ENTA Evolus Inc NASDAQ: EOLS Kura Oncology Inc NASDAQ: KURA Madrigal Pharmaceuticals Inc NASDAQ: MDGL Second Sight Medical Products Inc NASDAQ: EYES Spectrum Pharmaceuticals, Inc. NASDAQ: SPPI Therapix Biosciences Ltd ADR NASDAQ: TRPX Related Link: 7 Blockbuster Drugs Expected To Be Launched In 2020 Stocks In Focus Kura Oncology Announces Departure of Chief Medical Officer Kura Oncology said Antonio Gualberto, serving as Head of Development and Chief Medical Officer, will leave to pursue other opportunities. 